- Home
- CHE vs TEM Comparison
CHE vs TEM Comparison
Compare CHE & TEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHE
- TEM
- Stock Information
- Founded
- CHE 1970
- TEM 2015
- Country
- CHE United States
- TEM United States
- Employees
- CHE N/A
- TEM N/A
- Industry
- CHE Medical/Nursing Services
- TEM
- Sector
- CHE Health Care
- TEM
- Exchange
- CHE Nasdaq
- TEM NYSE
- Market Cap
- CHE 8.0B
- TEM 6.3B
- IPO Year
- CHE N/A
- TEM 2024
- Fundamental
- Price
- CHE $533.96
- TEM $31.83
- Analyst Decision
- CHE Buy
- TEM Buy
- Analyst Count
- CHE 2
- TEM 11
- Target Price
- CHE $641.50
- TEM $57.20
- AVG Volume (30 Days)
- CHE 100.0K
- TEM 4.0M
- Earning Date
- CHE 02-25-2025
- TEM 02-17-2025
- Dividend Yield
- CHE 0.34%
- TEM N/A
- EPS Growth
- CHE 22.57
- TEM N/A
- EPS
- CHE 19.78
- TEM N/A
- Revenue
- CHE $2,377,206,000.00
- TEM $640,442,000.00
- Revenue This Year
- CHE $8.28
- TEM $32.70
- Revenue Next Year
- CHE $7.06
- TEM $38.77
- P/E Ratio
- CHE $26.99
- TEM N/A
- Revenue Growth
- CHE 6.83
- TEM 32.13
- 52 Week Low
- CHE $512.12
- TEM $22.89
- 52 Week High
- CHE $654.62
- TEM $79.49
- Technical
- Relative Strength Index (RSI)
- CHE 48.79
- TEM N/A
- Support Level
- CHE $520.16
- TEM N/A
- Resistance Level
- CHE $535.09
- TEM N/A
- Average True Range (ATR)
- CHE 9.17
- TEM 0.00
- MACD
- CHE 1.99
- TEM 0.00
- Stochastic Oscillator
- CHE 83.42
- TEM 0.00
About CHE Chemed Corp
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
About TEM TEMPUS AI INC
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.